Study on mechanism of the coupling between bone resorption and bone formation

骨吸收与骨形成耦合机制研究

基本信息

  • 批准号:
    13557155
  • 负责人:
  • 金额:
    $ 8.96万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2003
  • 项目状态:
    已结题

项目摘要

Aim of the study :The discovery of RANKL elucidates the mechanism of osteoclast differentiation and function regulated by osteoblasts. Osteoprotegerin (OPG), a soluble decoy receptor of RANKL, inhibits both differentiation and function of osteoclasts. OPG-deficient (OPG-/-) mice exhibited severe osteoporosis caused by enhanced osteoclastic bone resorption. Deficiency of OPG in human has been shown to result in juvenile Paget's disease. The previous morphological study showed that osteoblastic bone formation was activated in OPG-/-mice. These results suggest that osteoclastic bone resorption coincidentally induces osteoblastic bone formation by an unknown factor (called coupling factor). In the present study, we examined a possibility that mature osteoclasts produce cytokines which influence bone metabolism using mature osteoclasts treated with LPS. Using OPG -/-mice, we also explored whether such a coupling factor is present in bone in OPG -/-mice.Results :(1)p38MAP kinase was essentia … More lly involved in the differentiation of bone marrow macrophages (osteoclast precursors) into osteoclasts. The p38MAP kinase-signaling pathway was all dead in mature osteoclasts. (2)Mature osteoclasts were shown to produce an osteoblast-activating factor but not bone-resorbing cytokines such as IL-1 and IL-6 in response to LPS. (3)Blood levels of osteocalcin and ALP of OPG-/-mice were markedly increased in OPG-/-mice. Bone histomorphometric studies showed that both bone resorption and bone formation were activated in OPG-/-mice. (4)Serum levels of soluble RANKL were also elevated in OPG-/-mice. (5)When 1,25(OH)_2D_3 was administered into OPG -/-and wild-type mice, serum RANKL concentrations were markedly increased in OPG-/-mice but not in wild-type mice. (6)OPO -/-osteoblasts released a large amount of RANKL in the culture medium, which was completely inhibited by adding OPG (7)When bisphosphonate (risedronate) was injected into OPG -/-mice, bone formation -related parameters as well as bone resorption-related parameters were sharply decreased in the treated mice. (8)Treatment of OPG -/-mice with risedronate decreased serum osteocalcin and ALP levels but not the serum RANKL level. (9)Ectopic bone formation induced by BMP is not accelerated in OPG -/-mice.Conclusion :These results suggest (1)that mature osteoclast produce a coupling factor but not bone resorbing factors, and (2)that bone resorption is tightly coupled with bone formation at the sites where borne resorption takes place. Less
造成骨质细胞差异和功能的机制,pg是一种可溶性的诱饵受体,抑制了由骨质骨的骨骼疾病增强的骨质骨化。在opg - / - 小鼠中激活了骨的骨骼。在OPG中 - /(1)P38 MAP激酶是骨骼巨噬细胞(破骨细胞前体)中的骨骼IL-6对OPG的LPS - / - 鼠标的标志性增加了。 OPG - / - 和野生型小鼠,在野生型小鼠中,OPG的血清RANKL贡献显着增加。随着骨度假胜地相关的参数在处理的小鼠中急剧降低,而不是血清rankl水平。坐在伯恩·伯恩(Borne Borne)的地方少了。

项目成果

期刊论文数量(100)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yasuhiro Kobayashi, Toshihide Mizoguchi, Ikuko Take, Saburo Kurihara, Nobuyuki Udagawa, Naoyuki Takahashi.: "Cyclic AMP/protein kinase A signals enhance osteoclastic differentiation through TAK1 in osteoclast precursors."(Submitted for publication.).
Yasuhiro Kobayashi、Toshihide Mizoguchi、Ikuko Take、Saburo Kurihara、Nobuyuki Udakawa、Naoyuki Takahashi.:“环化 AMP/蛋白激酶 A 信号通过破骨细胞前体中的 TAK1 增强破骨细胞分化。”(已提交出版)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sato J, Fukuda S, Takahashi N, Sato R, Yasuda J, Naito Y: "Effect of EDTA on Ca metabolism and bone metabolism in a cow."J. Vet Med (Tokyo). 56. 710-714 (2003)
Sato J、Fukuda S、Takahashi N、Sato R、Yasuda J、Naito Y:“EDTA 对奶牛钙代谢和骨代谢的影响。”J。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Katagiri T, Imada M, Yanai T, Suda T, Takahashi N, Kamijo R: "Identification of a BMP-responsive Element in the Id1 gene."Genes Cells. 7. 949-960 (2002)
Katagiri T、Imada M、Yanai T、Suda T、Takahashi N、Kamijo R:“Id1 基因中 BMP 响应元件的鉴定。”基因细胞。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Li X., et al.: "p38 MAPK is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis or dendritic cell differentiation of bone marrow macrophages."Endocrinology. 144. 4999-5005 (2003)
Li X. 等人:“p38 MAPK 在破骨细胞分化中至关重要,但不参与骨髓巨噬细胞的细胞因子产生、吞噬作用或树突状细胞分化。”内分泌学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda B, Takahashi K, Furuya T, Ishiyama S, Kim KJ, Saito S, Nishikawa T, Takahashi N, Togari A, Tomatsu T, Suda T, Kamatani N: "Activated human T cells directly induce osteoclastogenesis from human monocytes
小竹 S、宇田川 N、箱田 M、茂木 M、矢野 K、津田 B、高桥 K、古也 T、石山 S、金 KJ、斋藤 S、西川 T、高桥 N、户嘉 A、户松 T、须田 T、镰谷 N
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKAHASHI Naoyuki其他文献

TAKAHASHI Naoyuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKAHASHI Naoyuki', 18)}}的其他基金

Do carbon nanotubes control bone remodeling?
碳纳米管控制骨重塑吗?
  • 批准号:
    24659833
  • 财政年份:
    2012
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Role of Wnt-Ror2 signals in ruffled border formation in osteoclasts
Wnt-Ror2 信号在破骨细胞皱褶边界形成中的作用
  • 批准号:
    22659339
  • 财政年份:
    2010
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Analysis of osteoclast niche regulated by Wnt signals.
Wnt信号调控的破骨细胞生态位分析。
  • 批准号:
    22390351
  • 财政年份:
    2010
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The relationship between cell proliferation and RANKL-induced osteoclastogenesis
细胞增殖与RANKL诱导的破骨细胞生成的关系
  • 批准号:
    18390495
  • 财政年份:
    2006
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study on the molecular mechanism of alveolus bone resorption induced periodontal diseases
牙槽骨吸收诱发牙周病的分子机制研究
  • 批准号:
    16390535
  • 财政年份:
    2004
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Signal transduction and cell-to-cell communication in the bone resorption induced by inflammation
炎症诱导的骨吸收中的信号转导和细胞间通讯
  • 批准号:
    14370599
  • 财政年份:
    2002
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The invention of interstitial-type metal nitride thin films with opto-agilent function and their device fabrication
具有光安捷功能的间隙型金属氮化物薄膜的发明及其器件制备
  • 批准号:
    13305047
  • 财政年份:
    2001
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Analysis of signal transduction of inflammatory cytokines in bone destruction
骨破坏中炎症细胞因子的信号转导分析
  • 批准号:
    12470393
  • 财政年份:
    2000
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study on signal transduction in osteoclastogenesis for the development of anti-osteoporosis drugs.
破骨细胞生成信号转导研究,用于抗骨质疏松药物的开发。
  • 批准号:
    11557139
  • 财政年份:
    1999
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Study on osteoclast activiting factor expressed by osteoblasts/stromal cells
成骨细胞/基质细胞表达的破骨细胞激活因子的研究
  • 批准号:
    10470394
  • 财政年份:
    1998
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似国自然基金

分级微球控释系统介导VAO型破骨细胞促进ONFH修复再生的研究
  • 批准号:
    32371403
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
MS4A6D调控破骨细胞分化与功能的机制研究
  • 批准号:
    82371735
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
SDC1介导有氧糖酵解特异性靶向调控破骨细胞骨吸收功能在骨质疏松治疗中的机制研究
  • 批准号:
    82301760
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
破骨细胞通过Tctex-1外泌体途径促进软骨细胞基质小泡释放及OA早期软骨钙化的机制研究
  • 批准号:
    82302747
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
FSH介导AKT/FOXO1通路激活破骨细胞调控绵羊氟骨症转换的机制
  • 批准号:
    32373084
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
  • 批准号:
    24K19237
  • 财政年份:
    2024
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanisms of osteocyte induction and regulation of pathogen-induced osteolysis
骨细胞诱导机制和病原体引起的骨溶解的调节
  • 批准号:
    10648513
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
Drug delivery system of osteoclast differentiation inhibitor with carbonate apatite
碳酸磷灰石破骨细胞分化抑制剂的给药系统
  • 批准号:
    23K16044
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Osteoclast fusion and regulation by DC-STAMP and OC-STAMP
DC-STAMP 和 OC-STAMP 的破骨细胞融合和调节
  • 批准号:
    23K16132
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Osteoclast programming and reprogramming during osteoclastogenesis
破骨细胞生成过程中的破骨细胞编程和重编程
  • 批准号:
    10776112
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了